Overview of Mpox Outbreak in Greece in 2022-2023: Is It Over?
mpox
orthopoxvirus
outbreak
response
vaccination
virus
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
16 06 2023
16 06 2023
Historique:
received:
23
05
2023
revised:
11
06
2023
accepted:
14
06
2023
medline:
29
6
2023
pubmed:
28
6
2023
entrez:
28
6
2023
Statut:
epublish
Résumé
In May 2022, for the first time, multiple cases of mpox were reported in several non-endemic countries. The first ever case of the disease in Greece was confirmed on 8 June 2022, and a total of 88 cases were reported in the country until the end of April 2023. A multidisciplinary response team was established by the Greek National Public Health Organization (EODY) to monitor and manage the situation. EODY's emergency response focused on enhanced surveillance, laboratory testing, contact tracing, medical countermeasures, and the education of health care providers and the public. Even though management of cases was considered successful and the risk from the disease was downgraded, sporadic cases continue to occur. Here, we provide epidemiological and laboratory features of the reported cases to depict the course of the disease notification rate. Our results suggest that measures for raising awareness as well as vaccination of high-risk groups of the population should be continued.
Identifiants
pubmed: 37376683
pii: v15061384
doi: 10.3390/v15061384
pmc: PMC10303940
pii:
doi:
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Euro Surveill. 2018 Sep;23(38):
pubmed: 30255836
PLoS Biol. 2022 Aug 23;20(8):e3001769
pubmed: 35998195
Euro Surveill. 2022 Jul;27(27):
pubmed: 35801519
Bull World Health Organ. 1972;46(5):593-7
pubmed: 4340218
Virology. 2005 Sep 15;340(1):46-63
pubmed: 16023693
Mol Biol Evol. 2020 May 1;37(5):1530-1534
pubmed: 32011700
Bacteriol Rev. 1973 Mar;37(1):1-18
pubmed: 4349404
Trop Med Int Health. 2022 Jul;27(7):604-605
pubmed: 35633308
Emerg Infect Dis. 2004 Mar;10(3):426-31
pubmed: 15109408
MMWR Morb Mortal Wkly Rep. 2022 Jun 03;71(22):734-742
pubmed: 35653347
Euro Surveill. 2021 Aug;26(32):
pubmed: 34387184
Euro Surveill. 2022 Jul;27(27):
pubmed: 35801518
Clin Infect Dis. 2014 Jan;58(2):260-7
pubmed: 24158414
Travel Med Infect Dis. 2023 Mar-Apr;52:102551
pubmed: 36746267
Lancet Infect Dis. 2019 Nov;19(11):1166
pubmed: 31657773
Emerg Infect Dis. 2021 Apr;27(4):
pubmed: 33756100
Emerg Infect Dis. 2020 Apr;26(4):782-785
pubmed: 32023204
J Med Virol. 2019 Apr;91(4):533-540
pubmed: 30357851
Viruses. 2020 Nov 05;12(11):
pubmed: 33167496
Future Microbiol. 2007 Feb;2(1):17-34
pubmed: 17661673
Clin Chem. 2004 Apr;50(4):702-8
pubmed: 14962998
Euro Surveill. 2022 Jun;27(22):
pubmed: 35656830
China CDC Wkly. 2021 Dec 3;3(49):1049-1051
pubmed: 34934514
Euro Surveill. 2022 Jun;27(22):
pubmed: 35656836
J Gen Virol. 2005 Oct;86(Pt 10):2661-2672
pubmed: 16186219
Ocul Immunol Inflamm. 2023 May 4;:1-6
pubmed: 37140328
N Engl J Med. 2004 Jan 22;350(4):342-50
pubmed: 14736926
Euro Surveill. 2022 Jun;27(26):
pubmed: 35775427